News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Mar / 2026

March 2026
M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

« Feb

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

Yvonne Awards 2026

Yvonne Awards 2026

AI vs Cancer: How Technology Is Fighting Inequality Worldwide

AI vs Cancer: How Technology Is Fighting Inequality Worldwide

When Modern Medicine Meets Spontaneous Healing: Dr. Jeff Rediger

When Modern Medicine Meets Spontaneous Healing: Dr. Jeff Rediger

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

OncoDaily Launches OncoDaily Breast

OncoDaily Launches OncoDaily Breast

Melvin L.K. Chua: This Work Was 7 Years in the Making

Melvin L.K. Chua: This Work Was 7 Years in the Making

Science, Screening, and Solidarity for Cancer Care in the Region - AUB Office of the President

Science, Screening, and Solidarity for Cancer Care in the Region - AUB Office of the President

OncoDaily Launches OncoDaily Lung

OncoDaily Launches OncoDaily Lung

Team UHN

Aug 18, 2024 9:12 am

Blog Posts

A new potential biomarker and therapeutic target for lung and other cancers – University Health Network

A new potential biomarker and therapeutic target for lung and other cancers – University Health Network

Headlines

DARE Trial: Phase II Study of ctDNA-Guided Intervention in ER+/HER2− Early Breast Cancer — Investigator Perspective

Tislelizumab Plus Chemotherapy in ES-SCLC Delivers Sustained Survival Benefit in Long-Term Follow-Up of RATIONALE-312

Proud to Share the Launch of the ASCO Africa Community of Practice - Radwa A. Yassin

How The Clairity Model Could Change Breast Cancer Risk Prediction

Cancer Treatment Revolution: The Device That Could Change Everything

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research Headlines ESMO MD Anderson Cancer Center immunotherapy NSCLC cancer treatment cancer awareness Research colorectal cancer ASCO24 Childhood Cancer clinical trials prostate cancer FDA AACR UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Robert Orlowski Myeloma NCI Pancreatic Cancer Vivek Subbiah Myeloma Paper of the Day National Cancer Institute American Society of Clinical Oncology Paolo Tarantino healthcare AI radiation oncology cervical cancer IASLC WHO ASCO25 Memorial Sloan Kettering Cancer Center Zainab Shinkafi-Bagudu multiple myeloma

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}